IceCure Medical (ICCM) Capital Expenditures Growth (1y) (2021 - 2026)
IceCure Medical (ICCM) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -11.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -47.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 106.98% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | IceCure Medical | 7.92 Mn | -193,612.29 | 295,000.00 | -750.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -750.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 90.63% |
| Jun 30, 2025 | -266.67% |
| Mar 31, 2025 | 78.57% |
| Dec 31, 2024 | -100.57% |
| Sep 30, 2024 | 58.44% |
| Jun 30, 2024 | 91.67% |
| Mar 31, 2024 | 88.80% |
| Dec 31, 2023 | -47.74% |
| Sep 30, 2023 | 74.16% |
| Jun 30, 2023 | 79.37% |
| Mar 31, 2023 | -73.61% |
| Dec 31, 2022 | 89.41% |
| Sep 30, 2022 | -175.93% |
| Jun 30, 2022 | -96.07% |
| Mar 31, 2022 | -108.70% |
| Dec 31, 2021 | 132.46% |
| Sep 30, 2021 | -129.79% |